While the SEC's non-GAAP measures and metrics have been around for some time, they still cause headaches for businesses when it comes to disclosures and financial statements. In this program, we will address how companies are currently applying non-GAAP guidance and metrics, and what can be done in response to SEC comment letters to avoid costly fines and penalties. Topics include:
- Non-GAAP measures and KPIs
- SEC staff guidance
- Recent comment letter trends
To provide finance and accounting professionals with the specialized knowledge they need to apply non-GAAP guidance and metrics to disclosures and financial statements.
SPEAKER:
Sheri Fabian, National Assurance Partner – SEC Services, BDO
Jeremiah Saunders, National Assurance Partner – SEC Services, BDO
-
Overview of Non-GAAP Measures & KPIs
– Regulation S-K 10(e) Regulation G Requirements
– SEC comment letters -
SEC Staff Guidance
– SEC Staff CD&I
– Financial statement
requirements
– Key performance indicators -
Recent Comment Letter Trends
– Other SEC guidance
– Pharmaceutical industry
– Inappropriate non-GAAP
adjustments
– COVID-19
• Identify the SEC rules addressing non-GAAP measures
• Identify common examples of non-GAAP measures
• Recognize Regulation G prohibitions regarding non-GAAP measures
• Identify the relative level of SEC scrutiny of non-GAAP measures
• Recognize specified SEC guidance regarding non-GAAP measures